DWP450 for Treating Moderate to Severe Glabellar Lines

Conditions: Moderate to Severe Glabellar Lines Interventions: Drug: DWP450; Drug: Botox ® Sponsors: Daewoong Pharmaceutical Co. LTD. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Botox | Research